Certara (CERT) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
15 May, 2026Opening remarks and agenda
Meeting called to order virtually, with shareholders able to submit questions online.
Directors and executive officers introduced, with special recognition for outgoing board members.
Meeting conducted in accordance with bylaws and proper notice provided to all shareholders.
Board and executive committee updates
Three directors, Arjun Bedi, Stephen McLean, and Jon Resnick, stood for re-election as Class III directors.
Cynthia Collins and Rose Crane recognized for their service as their board terms concluded.
Shareholder proposals
Three proposals presented: election of directors, ratification of RSM as auditor, and advisory vote on executive compensation.
Board recommended voting in favor of all proposals.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Certara
- Q1 2026 saw 1% revenue growth, $8.8M net loss, and a major divestiture completed.CERT
Q1 202614 May 2026 - FY 2025 revenue rose 9% to $418.8M; 2026 outlook is flat to 4% growth with a new CEO.CERT
Q4 20259 Apr 2026 - Director elections, auditor ratification, and executive pay are key 2026 meeting topics.CERT
Proxy filing3 Apr 2026 - Virtual annual meeting to vote on directors, auditor, and executive pay, with board support.CERT
Proxy filing3 Apr 2026 - AI-driven product launches and disciplined cost control set the stage for cautious 2026 growth.CERT
Barclays 28th Annual Global Healthcare Conference10 Mar 2026 - 2026 guidance reflects stable markets, strong biosimulation growth, and operational transformation.CERT
Leerink Global Healthcare Conference 20269 Mar 2026 - Operational rigor, AI innovation, and cloud migration drive growth amid evolving regulatory and market dynamics.CERT
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - Strong biotech demand, AI-driven innovation, and cloud adoption fuel growth amid regulatory shifts.CERT
Stephens Annual Investment Conference3 Feb 2026 - Q2 revenue up 3% to $93.3M, net loss $12.6M, guidance reiterated at $385M–$400M.CERT
Q2 20242 Feb 2026